CDIB Capital, the PE arm of Taiwan’s China Development Financial, recently closed its $405 million debut China fund for China. Paul Yang, president and CEO of CDF, explains how the strategy is differentiated
Q: A captive unit of China Development Financial (CDF) since 2006, CDIB Capital closed its first fund with third-party capital this year. What was the thinking? A: We were first allowed to make direct...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.